Jennie Ursum

Summary

Affiliation: Jan van Breemen Institute
Country: The Netherlands

Publications

  1. ncbi Protective effect of noninherited maternal HLA-DR antigens on rheumatoid arthritis development
    Anouk L Feitsma
    Departments of Immunohematology and Blood Transfusion and Rheumatology, Leiden University Medical Center, 2333 ZA, Leiden, The Netherlands
    Proc Natl Acad Sci U S A 104:19966-70. 2007
  2. ncbi Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study
    Jennie Ursum
    Jan van Breemen Institute, Dr Jan van Breemenstraat, 1056 AB Amsterdam, The Netherlands
    Arthritis Res Ther 10:R12. 2008
  3. ncbi Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems
    Jennie Ursum
    Jan van Breemen Institute, 1056 AB Amsterdam, The Netherlands
    Arthritis Res Ther 11:R75. 2009
  4. ncbi Prediction of walking disability by disease-related factors in patients with rheumatoid arthritis
    Marike van der Leeden
    Jan van Breemen Institute, Center for Rheumatology and Rehabilitation, Jan van Breemenstraat 2, 1056 AB Amsterdam, The Netherland
    J Rehabil Med 42:506-10. 2010
  5. ncbi Levels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study
    Jennie Ursum
    Jan van Breemen Institute, Department of Rheumatology, Dr, Jan van Breemenstraat 2, 1056 AB Amsterdam, The Netherlands
    Arthritis Res Ther 12:R8. 2010
  6. ncbi Prevalence of hand symptoms, impairments and activity limitations in rheumatoid arthritis in relation to disease duration
    Noortje C A Horsten
    Department of Rehabilitation Medicine, Jan van Breemen Institute, VU University Medical Centre, Amsterdam, The Netherlands
    J Rehabil Med 42:916-21. 2010
  7. ncbi Predictors of stenosing tenosynovitis in the hand and hand-related activity limitations in patients with rheumatoid arthritis
    Jennie Ursum
    Department of Rheumatology, Jan van Breemen Institute, Amsterdam, The Netherlands
    Arch Phys Med Rehabil 92:96-100. 2011
  8. ncbi Prevalence and course of forefoot impairments and walking disability in the first eight years of rheumatoid arthritis
    Marike van der Leeden
    Jan van Breemen Institute, Amsterdam, The Netherlands
    Arthritis Rheum 59:1596-602. 2008

Detail Information

Publications8

  1. ncbi Protective effect of noninherited maternal HLA-DR antigens on rheumatoid arthritis development
    Anouk L Feitsma
    Departments of Immunohematology and Blood Transfusion and Rheumatology, Leiden University Medical Center, 2333 ZA, Leiden, The Netherlands
    Proc Natl Acad Sci U S A 104:19966-70. 2007
    ..25; P = 0.003). These data show a protective NIMA-effect in a human autoimmune disease and indicate that a DERAA-positive mother can transfer protection against RA to her DERAA-negative child...
  2. ncbi Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study
    Jennie Ursum
    Jan van Breemen Institute, Dr Jan van Breemenstraat, 1056 AB Amsterdam, The Netherlands
    Arthritis Res Ther 10:R12. 2008
    ..The aim of our study was to investigate the association between arthritic disease activity and antibodies to mutated citrullinated vimentin (anti-MCV), because such a relation has been suggested...
  3. ncbi Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems
    Jennie Ursum
    Jan van Breemen Institute, 1056 AB Amsterdam, The Netherlands
    Arthritis Res Ther 11:R75. 2009
    ..The aim of this study was to examine seroconversion and the relationship with age and inflammation of autoantibodies in a large group of patients attending an outpatient rheumatology clinic...
  4. ncbi Prediction of walking disability by disease-related factors in patients with rheumatoid arthritis
    Marike van der Leeden
    Jan van Breemen Institute, Center for Rheumatology and Rehabilitation, Jan van Breemenstraat 2, 1056 AB Amsterdam, The Netherland
    J Rehabil Med 42:506-10. 2010
    ....
  5. ncbi Levels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study
    Jennie Ursum
    Jan van Breemen Institute, Department of Rheumatology, Dr, Jan van Breemenstraat 2, 1056 AB Amsterdam, The Netherlands
    Arthritis Res Ther 12:R8. 2010
    ....
  6. ncbi Prevalence of hand symptoms, impairments and activity limitations in rheumatoid arthritis in relation to disease duration
    Noortje C A Horsten
    Department of Rehabilitation Medicine, Jan van Breemen Institute, VU University Medical Centre, Amsterdam, The Netherlands
    J Rehabil Med 42:916-21. 2010
    ..To determine the prevalence of hand and wrist symptoms and impairments, and the resulting activity limitations in relation to disease duration in patients with rheumatoid arthritis...
  7. ncbi Predictors of stenosing tenosynovitis in the hand and hand-related activity limitations in patients with rheumatoid arthritis
    Jennie Ursum
    Department of Rheumatology, Jan van Breemen Institute, Amsterdam, The Netherlands
    Arch Phys Med Rehabil 92:96-100. 2011
    ..To identify early predictors of stenosing tenosynovitis in the hand and hand-related activity limitations in patients with rheumatoid arthritis (RA)...
  8. ncbi Prevalence and course of forefoot impairments and walking disability in the first eight years of rheumatoid arthritis
    Marike van der Leeden
    Jan van Breemen Institute, Amsterdam, The Netherlands
    Arthritis Rheum 59:1596-602. 2008
    ..To evaluate the prevalence and 8-year course of forefoot impairments and walking disability in patients with rheumatoid arthritis (RA)...